These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 27280799)

  • 1. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
    Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
    Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation.
    Capcha JMC; Rodrigues CE; Moreira RS; Silveira MD; Dourado P; Dos Santos F; Irigoyen MC; Jensen L; Garnica MR; Noronha IL; Andrade L; Gomes SA
    Am J Physiol Regul Integr Comp Physiol; 2020 Jan; 318(1):R135-R147. PubMed ID: 31596111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible Underlying Mechanisms for the Renoprotective Effect of Retinoic Acid-Pretreated Wharton's Jelly Mesenchymal Stem Cells against Renal Ischemia/Reperfusion Injury.
    Barakat M; Hussein AM; Salama MF; Awadalla A; Barakat N; Serria M; El-Shafey M; El-Sherbiny M; El Adl MA
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow vs Wharton's jelly mesenchymal stem cells in experimental sepsis: a comparative study.
    Laroye C; Boufenzer A; Jolly L; Cunat L; Alauzet C; Merlin JL; Yguel C; Bensoussan D; Reppel L; Gibot S
    Stem Cell Res Ther; 2019 Jun; 10(1):192. PubMed ID: 31248453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells.
    Du T; Zou X; Cheng J; Wu S; Zhong L; Ju G; Zhu J; Liu G; Zhu Y; Xia S
    Stem Cell Res Ther; 2013 Jun; 4(3):59. PubMed ID: 23734757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism.
    Du T; Cheng J; Zhong L; Zhao XF; Zhu J; Zhu YJ; Liu GH
    Cytotherapy; 2012 Nov; 14(10):1215-27. PubMed ID: 22920838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Wharton's jelly-derived mesenchymal stem cells prevent pregnancy loss in a rat by JAK/STAT-mediated immunomodulation.
    Ding X; Wu R; Jin B; Zhu C; Zhang Y; Yang X
    J Obstet Gynaecol Res; 2023 Oct; 49(10):2417-2426. PubMed ID: 37464974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury.
    Chudickova M; Vackova I; Machova Urdzikova L; Jancova P; Kekulova K; Rehorova M; Turnovcova K; Jendelova P; Kubinova S
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I mimetic peptide 4F attenuates kidney injury, heart injury, and endothelial dysfunction in sepsis.
    Moreira RS; Irigoyen M; Sanches TR; Volpini RA; Camara NO; Malheiros DM; Shimizu MH; Seguro AC; Andrade L
    Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(5):R514-24. PubMed ID: 24920733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats.
    Abd El Motteleb DM; Hussein S; Hasan MM; Mosaad H
    J Cell Biochem; 2018 Dec; 119(12):9790-9800. PubMed ID: 30171723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNAs are abundantly expressed and upregulated during repair of the damaged endometrium by Wharton's jelly-derived mesenchymal stem cells.
    Sun B; Shi L; Shi Q; Jiang Y; Su Z; Yang X; Zhang Y
    Stem Cell Res Ther; 2018 Nov; 9(1):314. PubMed ID: 30442201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of conditioned media derived from human Wharton's jelly mesenchymal stem cells on diabetic nephropathy and hepatopathy via modulating TGF-β and apelin signaling pathways in male rats.
    Karimi Z; Daryabor G; Masjedi F
    BMC Endocr Disord; 2024 Jan; 24(1):6. PubMed ID: 38178017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1.
    Zou X; Zhang G; Cheng Z; Yin D; Du T; Ju G; Miao S; Liu G; Lu M; Zhu Y
    Stem Cell Res Ther; 2014 Mar; 5(2):40. PubMed ID: 24646750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.
    Sabbaghziarani F; Mortezaee K; Akbari M; Kashani IR; Soleimani M; Moini A; Ataeinejad N; Zendedel A; Hassanzadeh G
    Metab Brain Dis; 2017 Feb; 32(1):185-193. PubMed ID: 27549229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wharton's Jelly Mesenchymal Stem Cells Protect the Immature Brain in Rats and Modulate Cell Fate.
    Mueller M; Oppliger B; Joerger-Messerli M; Reinhart U; Barnea E; Paidas M; Kramer BW; Surbek DV; Schoeberlein A
    Stem Cells Dev; 2017 Feb; 26(4):239-248. PubMed ID: 27842457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
    Liau LL; Ruszymah BHI; Ng MH; Law JX
    Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single high-dose intravenous injection of Wharton's jelly-derived mesenchymal stem cell exerts protective effects in a rat model of metabolic syndrome.
    Chan AML; Ng AMH; Yunus MHM; Idrus RH; Law JX; Yazid MD; Chin KY; Yusof MRM; Ng SN; Koh B; Lokanathan Y
    Stem Cell Res Ther; 2024 Jun; 15(1):160. PubMed ID: 38835014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Injectable Hyaluronan-Methylcellulose (HAMC) Hydrogel Combined with Wharton's Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair.
    Choi UY; Joshi HP; Payne S; Kim KT; Kyung JW; Choi H; Cooke MJ; Kwon SY; Roh EJ; Sohn S; Shoichet MS; Han I
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells.
    Rengasamy M; Singh G; Fakharuzi NA; Siddikuzzaman ; Balasubramanian S; Swamynathan P; Thej C; Sasidharan G; Gupta PK; Das AK; Rahman AZA; Fakiruddin KS; Nian LM; Zakaria Z; Majumdar AS
    Stem Cell Res Ther; 2017 Jun; 8(1):143. PubMed ID: 28610623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.